Progression-Free Survival and Overall Survival in Patients with Advanced HER2-Positive Breast Cancer Treated with Trastuzumab Emtansine (T-DM1) after Previous Treatment with Pertuzumab

SIMPLE SUMMARY: Data about the efficacy of trastuzumab emtansine (T-DM1) following pertuzumab treatment is limited due to the simultaneous development of the two drugs. Thus, the aim of this study was to investigate the efficacy of T-DM1 after previous treatment with pertuzumab in a large, real-worl...

Descripción completa

Detalles Bibliográficos
Autores principales: Michel, Laura L., Hartkopf, Andreas D., Fasching, Peter A., Kolberg, Hans-Christian, Hadji, Peyman, Tesch, Hans, Häberle, Lothar, Ettl, Johannes, Lüftner, Diana, Wallwiener, Markus, Müller, Volkmar, Beckmann, Matthias W., Belleville, Erik, Volz, Bernhard, Huebner, Hanna, Wimberger, Pauline, Hielscher, Carsten, Mundhenke, Christoph, Kurbacher, Christian, Wuerstlein, Rachel, Untch, Michael, Overkamp, Friedrich, Huober, Jens, Janni, Wolfgang, Taran, Florin-Andrei, Lux, Michael P., Wallwiener, Diethelm, Brucker, Sara Y., Schneeweiss, Andreas, Fehm, Tanja N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7603111/
https://www.ncbi.nlm.nih.gov/pubmed/33080911
http://dx.doi.org/10.3390/cancers12103021

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7603111/
https://www.ncbi.nlm.nih.gov/pubmed/33080911
http://dx.doi.org/10.3390/cancers12103021

Ejemplares similares